Traders Purchase High Volume of Teladoc Health Call Options (NYSE:TDOC)

Key Points

• Teladoc Health experienced a significant increase in call options trading, with a reported volume of 55,189, marking a 138% increase compared to the average.
• Institutional ownership of Teladoc Health is high, with 76.82% of the stock held by institutional investors and hedge funds, including substantial increases in holdings by firms such as Golden State Wealth Management and Caitong International Asset Management.
• Analysts have mixed views on Teladoc Health, with a consensus rating of "Hold" and a price target of $9.86, while research firms have given varying ratings from "Buy" to "Sell."

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders purchased 55,189 call options on the stock. This represents an increase of approximately 138% compared to the typical volume of 23,145 call options.

Institutional Trading of Teladoc Health

Large investors have recently modified their holdings of the business. Golden State Wealth Management LLC grew its position in shares of Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares during the last quarter. National Bank of Canada FI grew its position in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC acquired a new stake in shares of Teladoc Health in the first quarter valued at approximately $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Teladoc Health in the first quarter valued at approximately $50,000. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of Teladoc Health by 8,192.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider's stock valued at $72,000 after purchasing an additional 8,192 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have issued reports on TDOC. Evercore ISI upped their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research note on Wednesday. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday. Finally, Mizuho assumed coverage on shares of Teladoc Health in a research note on Friday, July 25th. They set a "neutral" rating and a $10.00 target price for the company. Six research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of "Hold" and a consensus price target of $9.86.

Teladoc Health Price Performance

Teladoc Health stock traded up $0.71 during mid-day trading on Wednesday, reaching $9.08. The company had a trading volume of 9,238,137 shares, compared to its average volume of 6,855,266. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The company has a market capitalization of $1.60 billion, a P/E ratio of -7.61 and a beta of 1.90. The stock's 50-day simple moving average is $7.68 and its 200-day simple moving average is $7.60.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. During the same period last year, the company posted ($0.38) earnings per share. The firm's quarterly revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities analysts predict that Teladoc Health will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.